LENSAR, Inc. (LNSR)Healthcare | Medical Devices | Orlando, United States | NasdaqCM
6.27 USD
+0.05
(0.804%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 8:01 a.m. EDT
The investment thesis here is entirely dependent on the resolution of the Alcon acquisition saga. While the company boasts impressive top-line growth (+18.4%) and healthy gross margins (48%), the balance sheet is currently bleeding cash with negative free cash flow and negative operating cash flow, making it a classic high-risk turnaround play. The market has punished the stock severely following the failed deal, driving the price down from highs near $12 to current levels around $6.40. However, the options market tells a different story: there is a distinct 'wall' of open interest at the $10 strike across multiple expirations, which aligns perfectly with the analyst mean target of $11.33. This suggests the market is pricing in a successful deal completion or a strategic pivot that will unlock value. The statistical forecast model is weak and leans slightly negative, reflecting the recent volatility and uncertainty, but this is secondary to the fundamental potential if the regulatory hurdles clear. For now, the stock trades at a discount to book value relative to its growth profile, but the lack of dividends and negative cash flow means this is purely a capital appreciation bet on a specific catalyst. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.275542 |
| AutoETS | 0.282283 |
| MSTL | 0.323789 |
| AutoARIMA | 0.343415 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 3.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.088 |
| Excess Kurtosis | -0.96 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 8.299 |
| Revenue per Share | 4.962 |
| Market Cap | 77,032,376 |
| Trailing P/E | 34.83 |
| Forward P/E | -12.29 |
| Beta | 0.95 |
| Profit Margins | 57.57% |
| Website | https://www.lensar.com |
As of Oct. 10, 2026, 8:01 a.m. EDT: Speculators are positioning for a significant gap-up to the $10 strike, evidenced by massive open interest in October and January calls at that level compared to negligible volume elsewhere. Conversely, put writers are heavily concentrated at the $5 strike, creating a floor around current prices, while call writers are also stacking at $10, suggesting a consensus expectation of a binary event or merger arbitrage convergence rather than organic linear growth.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.46425498 |
| Address1 | 2,800 Discovery Drive |
| All Time High | 17.31 |
| All Time Low | 1.8 |
| Ask | 8.0 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 37,380 |
| Average Daily Volume3 Month | 103,531 |
| Average Volume | 103,531 |
| Average Volume10Days | 37,380 |
| Beta | 0.946 |
| Bid | 4.47 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 1.214 |
| City | Orlando |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.27 |
| Current Ratio | 2.394 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 6.32 |
| Day Low | 6.205 |
| Debt To Equity | 8.299 |
| Display Name | LENSAR |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,624,200 |
| Earnings Call Timestamp Start | 1,786,624,200 |
| Earnings Timestamp | 1,786,624,200 |
| Earnings Timestamp End | 1,794,486,600 |
| Earnings Timestamp Start | 1,794,486,600 |
| Ebitda | -16,328,000 |
| Ebitda Margins | -0.27094 |
| Enterprise To Ebitda | -4.877 |
| Enterprise To Revenue | 1.321 |
| Enterprise Value | 79,632,376 |
| Eps Current Year | -0.05 |
| Eps Forward | -0.51 |
| Eps Trailing Twelve Months | 0.18 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.3744 |
| Fifty Day Average Change | -1.1044002 |
| Fifty Day Average Change Percent | -0.14976135 |
| Fifty Two Week Change Percent | -46.4255 |
| Fifty Two Week High | 12.94 |
| Fifty Two Week High Change | -6.6699996 |
| Fifty Two Week High Change Percent | -0.51545596 |
| Fifty Two Week Low | 4.95 |
| Fifty Two Week Low Change | 1.3200002 |
| Fifty Two Week Low Change Percent | 0.2666667 |
| Fifty Two Week Range | 4.95 - 12.94 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,601,645,400,000 |
| Float Shares | 8,842,506 |
| Forward Eps | -0.51 |
| Forward P E | -12.294118 |
| Free Cashflow | -24,391,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 150 |
| Fullday Change | 0.05000019 |
| Fullday Change Percent | 0.8038616 |
| Fullday Price | 6.27 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.48339 |
| Gross Profits | 29,131,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.21521999 |
| Held Percent Institutions | 0.45966998 |
| Implied Shares Outstanding | 12,285,865 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. |
| Long Name | LENSAR, Inc. |
| Market | us_market |
| Market Cap | 77,032,376 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_41699596 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 14,700,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 87,843,934 |
| Number Of Analyst Opinions | 3 |
| Open | 6.205 |
| Operating Cashflow | -7,293,000 |
| Operating Margins | 0.12937 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 888 536 7271 |
| Previous Close | 6.22 |
| Price Eps Current Year | -125.4 |
| Price Hint | 2 |
| Price To Book | 5.164745 |
| Price To Sales Trailing12 Months | 1.2782487 |
| Profit Margins | 0.57573 |
| Quick Ratio | 1.03 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0500002 |
| Regular Market Change Percent | 0.803862 |
| Regular Market Day High | 6.32 |
| Regular Market Day Low | 6.205 |
| Regular Market Day Range | 6.205 - 6.32 |
| Regular Market Open | 6.205 |
| Regular Market Previous Close | 6.22 |
| Regular Market Price | 6.27 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 23,868 |
| Return On Assets | -0.18663 |
| Return On Equity | 3.5730398 |
| Revenue Growth | 0.184 |
| Revenue Per Share | 4.962 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 12,285,865 |
| Shares Percent Shares Out | 0.026199998 |
| Shares Short | 322,414 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 381,943 |
| Short Name | LENSAR, Inc. |
| Short Percent Of Float | 0.0363 |
| Short Ratio | 4.9 |
| Source Interval | 15 |
| State | FL |
| Symbol | LNSR |
| Target High Price | 13.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 11.33333 |
| Target Median Price | 11.0 |
| Total Cash | 13,565,000 |
| Total Cash Per Share | 1.104 |
| Total Debt | 2,381,000 |
| Total Revenue | 60,264,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.18 |
| Trailing P E | 34.833332 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.8536 |
| Two Hundred Day Average Change | -1.5836 |
| Two Hundred Day Average Change Percent | -0.20164001 |
| Type Disp | Equity |
| Volume | 23,868 |
| Website | https://www.lensar.com |
| Zip | 32,826 |